Automation of radiation treatment planning for rectal cancer.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 10 06 2022
received: 22 03 2022
accepted: 13 06 2022
pubmed: 10 7 2022
medline: 28 9 2022
entrez: 9 7 2022
Statut: ppublish

Résumé

To develop an automated workflow for rectal cancer three-dimensional conformal radiotherapy (3DCRT) treatment planning that combines deep learning (DL) aperture predictions and forward-planning algorithms. We designed an algorithm to automate the clinical workflow for 3DCRT planning with field aperture creations and field-in-field (FIF) planning. DL models (DeepLabV3+ architecture) were trained, validated, and tested on 555 patients to automatically generate aperture shapes for primary (posterior-anterior [PA] and opposed laterals) and boost fields. Network inputs were digitally reconstructed radiographs, gross tumor volume (GTV), and nodal GTV. A physician scored each aperture for 20 patients on a 5-point scale (>3 is acceptable). A planning algorithm was then developed to create a homogeneous dose using a combination of wedges and subfields. The algorithm iteratively identifies a hotspot volume, creates a subfield, calculates dose, and optimizes beam weight all without user intervention. The algorithm was tested on 20 patients using clinical apertures with varying wedge angles and definitions of hotspots, and the resulting plans were scored by a physician. The end-to-end workflow was tested and scored by a physician on another 39 patients. The predicted apertures had Dice scores of 0.95, 0.94, and 0.90 for PA, laterals, and boost fields, respectively. Overall, 100%, 95%, and 87.5% of the PA, laterals, and boost apertures were scored as clinically acceptable, respectively. At least one auto-plan was clinically acceptable for all patients. Wedged and non-wedged plans were clinically acceptable for 85% and 50% of patients, respectively. The hotspot dose percentage was reduced from 121% (σ = 14%) to 109% (σ = 5%) of prescription dose for all plans. The integrated end-to-end workflow of automatically generated apertures and optimized FIF planning gave clinically acceptable plans for 38/39 (97%) of patients. We have successfully automated the clinical workflow for generating radiotherapy plans for rectal cancer for our institution.

Identifiants

pubmed: 35808871
doi: 10.1002/acm2.13712
pmc: PMC9512348
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13712

Subventions

Organisme : the MD Anderson Cancer Center Institutional Research Grant

Informations de copyright

© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Jpn J Radiol. 2010 May;28(4):283-9
pubmed: 20512546
Med Dosim. 2004 Winter;29(4):265-70
pubmed: 15528068
Semin Radiat Oncol. 1993 Jan;3(1):42-47
pubmed: 10717051
Pract Radiat Oncol. 2020 Sep - Oct;10(5):e415-e424
pubmed: 32450365
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818810391
pubmed: 30384804
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Jpn J Radiol. 2012 Apr;30(3):218-26
pubmed: 22183829
Pract Radiat Oncol. 2021 Jan-Feb;11(1):13-25
pubmed: 33097436
Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):187-94
pubmed: 10656392
Radiat Oncol J. 2013 Dec;31(4):252-9
pubmed: 24501715
Jpn J Clin Oncol. 2008 Feb;38(2):158-63
pubmed: 18216025
J Appl Clin Med Phys. 2022 Sep;23(9):e13712
pubmed: 35808871
J Glob Oncol. 2019 Jan;5:1-9
pubmed: 30629457
Med Dosim. 2004 Summer;29(2):109-14
pubmed: 15191757
Phys Med. 2013 Nov;29(6):577-82
pubmed: 23219336
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cancer Res Ther. 2009 Jan-Mar;5(1):20-3
pubmed: 19293484
Australas Phys Eng Sci Med. 2008 Dec;31(4):317-24
pubmed: 19239058
Radiat Oncol. 2019 Mar 27;14(1):53
pubmed: 30917848
Med Phys. 2019 Sep;46(9):3767-3775
pubmed: 31077593

Auteurs

Kai Huang (K)

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Prajnan Das (P)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Adenike M Olanrewaju (AM)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Carlos Cardenas (C)

Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

David Fuentes (D)

Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Lifei Zhang (L)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Donald Hancock (D)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Hannah Simonds (H)

Department of Radiation Oncology, Tygerberg Hospital Stellenbosch University, Stellenbosch, South Africa.

Dong Joo Rhee (DJ)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Sam Beddar (S)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Tina M Briere (TM)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Laurence Court (L)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH